These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29549588)

  • 1. Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Kerrouche N; Tan J
    Am J Clin Dermatol; 2018 Apr; 19(2):275-286. PubMed ID: 29549588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
    Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the effect of adapalene 0.3%/benzoyl peroxide 2.5% gel in Korean patients with acne: a randomized, double-blind clinical trial, with a histopathological and immunohistochemical study.
    Lee JH; Kim DH; Yoon JY; Kim TM; Kim SR; Suh DH
    Ital J Dermatol Venerol; 2024 Aug; 159(4):444-452. PubMed ID: 39069843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Topical Retinoids in Prevention and Treatment of Atrophic Acne Scarring: Understanding the Importance of Early Effective Treatment.
    Tan J; Tanghetti E; Baldwin H; Stein Gold L; Lain E
    J Drugs Dermatol; 2019 Mar; 18(3):255-260. PubMed ID: 30909329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial.
    Dreno B; Tan J; Rivier M; Martel P; Bissonnette R
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):737-742. PubMed ID: 27790756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of maintenance therapy for acne vulgaris using adapalene 0.1%/benzoyl peroxide 2.5% gel and benzoyl peroxide 2.5% gel for 24 weeks and assessment of atrophic acne scars using three-dimensional image analysis.
    Tanizaki H; Hayashi N; Abe M
    J Dermatol; 2023 Dec; 50(12):1513-1522. PubMed ID: 37665181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
    Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
    J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
    J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes.
    Alexis AF; Cook-Bolden FE; York JP
    J Drugs Dermatol; 2017 Jun; 16(6):574-581. PubMed ID: 28686775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Double-Blinded, Randomized, Vehicle-Controlled Study of the Efficacy of Moisturizer Containing Licochalcone A, Decanediol, L-Carnitine, and Salicylic Acid for Prevention of Acne Relapse in Asian Population.
    Kulthanan K; Trakanwittayarak S; Tuchinda P; Chularojanamontri L; Limphoka P; Varothai S
    Biomed Res Int; 2020; 2020():2857812. PubMed ID: 33150170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
    Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
    Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
    Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
    J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: Effective Acne Therapy Regardless of Age or Gender.
    Stein Gold L; Werschler WP; Mohawk J
    J Drugs Dermatol; 2017 Jun; 16(6):582-589. PubMed ID: 28686776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the Use of 0.3% Adapalene/2.5% Benzoyl Peroxide Gel for the Management of Moderate-to-Severe Acne in Indian Patients: A Phase 4 Study Assessing Safety and Efficacy.
    Batra R; Yogendra M; Gaurkar S; Mukhopadhyay P; Sen D; Jadhwar S
    Cureus; 2024 Jul; 16(7):e65894. PubMed ID: 39219919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
    Stein Gold L; Baldwin H; Kircik LH; Weiss JS; Pariser DM; Callender V; Lain E; Gold M; Beer K; Draelos Z; Sadick N; Pillai R; Bhatt V; Tanghetti EA
    Am J Clin Dermatol; 2022 Jan; 23(1):93-104. PubMed ID: 34674160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.
    Poulin Y; Sanchez NP; Bucko A; Fowler J; Jarratt M; Kempers S; Kerrouche N; Dhuin JC; Kunynetz R
    Br J Dermatol; 2011 Jun; 164(6):1376-82. PubMed ID: 21457209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.